Welcome to VanEck
Select Investor Type
Source: VanEck.
The ETF is inspired by a pure-play investment approach by focusing on companies with significant exposure to genomics and digital healthcare activities. ESG screening criteria are applied in line with its sustainable investment objective, providing targeted exposure to an innovative segment of the healthcare sector.
Main risk factors include Equity Market Risk, Industry Concentration Risk and Liquidity Risk. You can lose money by investing in the Funds; the value of investments may go up or down and investors may not get back the amount invested.
The world changes too much to leave investments on auto-pilot, so our goal is to challenge you to re-think your portfolio. For nearly 70 years, VanEck has built forward-looking, intelligently designed solutions. We see beyond today’s financial markets to identify the trends that will fuel investable opportunities before they become mainstream.
Email: [email protected]
Email: [email protected]
Email: [email protected]
Email: [email protected]
Email: [email protected]
Email: [email protected]
5100 W Kennedy Blvd, Tampa, FL 33609
Email: [email protected]
Email: [email protected]
Email: [email protected]
Comprehensive global portfolio covering numerous sectors and asset classes
Allowing us to focus on our clients’ long-term interests
Martijn Rozemuller, CEO Europe
Bouke van den Berg, Co-Head Sales EMEA
André van Muijlwijk, Director, Sales and Business Development
Manuela Waldow, Director, Client Services & Sales Support
Jan van Eck, CEO
Torsten Hunke, General Counsel for Europe
Sabrina Giagheddu, Senior Legal Counsel
Dmitrii Ponomarev, Product Manager
Nibha Ritter, VP, Marketing Manager
Gijs Koning, COO Europe
Aaron Renkers, Head of Investments
Floor Klarenbeek, Head of Capital Markets Europe